Merck ramps up measles vaccine production amid outbreak

Merck has increased production of the measles vaccine to meet growing demand amid the country's largest outbreak in 25 years, according to Reuters.

Merck, the sole supplier of measles vaccines in the U.S., said that the increase in demand was noticeable, but it was able to handle the uptick.

"Despite what we've seen as a huge uptick in the number of cases ... the demand side of the equation hasn’t been outstripping our underlying capacity," Mike Nally, head of Merck's Global Human Health business and chief marketing officer, told Reuters.

As of April 26, the CDC had reported 704 cases of measles nationwide. Most cases were found in children who had not received the measles-mumps-rubella vaccine. The previous record was in 2014, when 667 measles cases were reported.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.